Natural Product: NPC328186

Natural Product IDNPC328186
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
VRFBNEKYXLBEOW-SOSGQWQHSA-N
IUPAC Name n.a.
Synonyms 9'-Deacetoxymekongensine
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL1811932
PubChem CID 56662659
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001283] Terpene lactones

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey VRFBNEKYXLBEOW-SOSGQWQHSA-N
Standard InCHI InChI=1S/C43H49NO18/c1-21-16-17-29-28(15-12-18-44-29)39(52)55-19-40(7)30-31(56-23(3)46)35(58-25(5)48)42(20-54-22(2)45)36(59-26(6)49)32(57-24(4)47)34(61-37(21)50)41(8,53)43(42,62-40)33(30)60-38(51)27-13-10-9-11-14-27/h9-15,18,21,30-36,53H,16-17,19-20H2,1-8H3/t21-,30+,31+,32-,33+,34-,35+,36-,40-,41-,42-,43-/m0/s1
SMILES CC(=O)OC[C@@]12[C@@H](OC(=O)C)[C@@H](OC(=O)C)[C@H]3[C@]([C@@]42O[C@@]([C@H]([C@H]([C@H]1OC(=O)C)OC(=O)C)[C@H]4OC(=O)c1ccccc1)(C)COC(=O)c1cccnc1CC[C@@H](C(=O)O3)C)(C)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   867.29 Volume:   833.255
?
Van der Waals volume.
Dense:   1.041 LogP:   0.919
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.352
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.219
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   14.0 Rigid Bonds:   44.0
TPSA:   252.75
?
Topological Polar Surface Area.
H-Bond Acceptor:   19.0
H-Bond Donor:   1.0 Rings:   6.0
Heavy Atoms:   19.0

MedChem Properties

QED Drug-Likeness Score:   0.295 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   7.521 Fsp3:   0.558
MCE-18:   217.94
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.584 Fluc inhibitor:   0.005
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.004
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.137
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.013 Promiscuous compounds:   0.097

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.307 MDCK Permeability:   -4.731
Pgp-inhibitor:   0.998 Pgp-substrate:   0.94
PAMPA:   0.951
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   0.008 30% Bioavailability (F30%):   0.32
50% Bioavailability (F50%):   0.761

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.001 MRP1:   1.0
Plasma Protein Binding (PPB):   61.021% Volume Distribution (VD):   -0.39
Fu: 37.663%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   0.96 BCRP inhibitor:   0.0
BSEP inhibitor:   0.967

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.998
HLM stability:   0.625
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  1.008 Half-life (T1/2):  1.313

ADMET: Toxicity

hERG Blockers:  0.006 hERG Blockers (10um):  0.091
Human Hepatotoxicity (H-HT):  0.496 Drug-induced Liver Injury (DILI):  0.994
AMES Toxicity:  0.97 Rat Oral Acute Toxicity:  0.45
Maximum Recommended Daily Dose:  0.566 Skin Sensitization:  1.0
Carcinogencity:  0.672 Eye Corrosion:  0.0
Eye Irritation:  0.035 Respiratory Toxicity:  0.053
Drug-induced Neurotoxicity:  0.407 Ototoxicity:  0.487
Hematotoxicity:  0.913 Drug-induced Nephrotoxicity:  0.994
Genotoxicity:  0.996 RPMI-8226 Immunitoxicity:  0.312
A549 Cytotoxicity:  0.445 Hek293 Cytotoxicity:  0.159
BCF:   0.538
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.417
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.884
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.472
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO30152 Maytenus mekongensis Species Celastraceae Eukaryota n.a. root n.a. PMID[21634414]
NPO40565 Maytenus spinosa Species Celastraceae Eukaryota n.a. n.a. n.a. PMID[25057904]
NPO40565 Maytenus spinosa Species Celastraceae Eukaryota n.a. n.a. n.a. Database[COCONUT]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT91 Cell line KB Homo sapiens IC50 = 46.7 ug.mL-1 PMID[21634414]
NPT485 Organism Plasmodium falciparum (isolate K1 / Thailand) Plasmodium falciparum K1 IC50 = 3100.0 nM PMID[21634414]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC328186 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9667 High Similarity NPC316841
0.913 High Similarity NPC122968
0.913 High Similarity NPC228377
0.8667 High Similarity NPC250807
0.8667 High Similarity NPC57797
0.8571 High Similarity NPC319880
0.8571 High Similarity NPC320324
0.8485 Intermediate Similarity NPC38959
0.83 Intermediate Similarity NPC327904
0.8061 Intermediate Similarity NPC475631
0.8 Intermediate Similarity NPC473689
0.8 Intermediate Similarity NPC292416
0.7938 Intermediate Similarity NPC53255
0.7938 Intermediate Similarity NPC85879
0.7921 Intermediate Similarity NPC244839
0.78 Intermediate Similarity NPC475596
0.7745 Intermediate Similarity NPC475406
0.7551 Intermediate Similarity NPC146824
0.7451 Intermediate Similarity NPC476110
0.7353 Intermediate Similarity NPC87152
0.7353 Intermediate Similarity NPC475600
0.7255 Intermediate Similarity NPC475303
0.7196 Intermediate Similarity NPC327769
0.7009 Intermediate Similarity NPC477787
0.697 Remote Similarity NPC473850
0.6952 Remote Similarity NPC13603
0.69 Remote Similarity NPC76565
0.69 Remote Similarity NPC601313
0.6762 Remote Similarity NPC475301
0.6759 Remote Similarity NPC253482
0.6759 Remote Similarity NPC600583
0.6759 Remote Similarity NPC601643
0.6729 Remote Similarity NPC30456
0.6729 Remote Similarity NPC488904
0.6577 Remote Similarity NPC471979
0.6455 Remote Similarity NPC237702
0.6455 Remote Similarity NPC475648
0.6422 Remote Similarity NPC475644
0.6408 Remote Similarity NPC471016
0.6355 Remote Similarity NPC326930
0.6325 Remote Similarity NPC483854
0.6271 Remote Similarity NPC482915
0.6262 Remote Similarity NPC475362
0.6147 Remote Similarity NPC607403
0.6091 Remote Similarity NPC470486
0.6053 Remote Similarity NPC328928
0.5946 Remote Similarity NPC328154
0.5946 Remote Similarity NPC471977
0.5897 Remote Similarity NPC475426
0.5862 Remote Similarity NPC483853
0.5862 Remote Similarity NPC608314
0.5789 Remote Similarity NPC483893
0.5789 Remote Similarity NPC600607
0.5789 Remote Similarity NPC611166
0.5755 Remote Similarity NPC470306
0.5701 Remote Similarity NPC35208
0.5664 Remote Similarity NPC477788
0.5652 Remote Similarity NPC483894
0.5545 Remote Similarity NPC475498
0.5528 Remote Similarity NPC483856
0.5505 Remote Similarity NPC475137
0.5478 Remote Similarity NPC471190
0.5439 Remote Similarity NPC475533
0.5357 Remote Similarity NPC483892
0.5345 Remote Similarity NPC324619
0.5214 Remote Similarity NPC483895
0.5214 Remote Similarity NPC600224
0.521 Remote Similarity NPC600546
0.5128 Remote Similarity NPC475315
0.5088 Remote Similarity NPC473833
0.5085 Remote Similarity NPC604935
0.5078 Remote Similarity NPC483855

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC328186 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data